00950nam0 22002651i 450 UON0015203920231205102926.65620020107f |0itac50 baperIR|||| 1||||Doxtar-e MohammadSeyyed Ja'far Sahidi[3. ed.]TehranKetabforusi Hafez[19..]108 p.20 cmIRTihrānUONL005570IRA VII BIRAN - RELIGIONE E FILOSOFIA - ISLAMASAHIDISeyyed Ja'farUONV089885673185Ketabforusi-e HafezUONV264513650ITSOL20240220RICASIBA - SISTEMA BIBLIOTECARIO DI ATENEOUONSIUON00152039SIBA - SISTEMA BIBLIOTECARIO DI ATENEOSI IRA VII B 024 SI MR 79838 7 024 Doxtar-e Mohammad1274659UNIOR03353nam 2200985z- 450 991055761010332120220321(CKB)5400000000045301(oapen)https://directory.doabooks.org/handle/20.500.12854/79654(oapen)doab79654(EXLCZ)99540000000004530120202203d2022 |y 0engurmn|---annantxtrdacontentcrdamediacrrdacarrierPharmacogenetics to Avoid Adverse Drug ReactionsBaselMDPI - Multidisciplinary Digital Publishing Institute20221 online resource (220 p.)3-0365-3344-3 3-0365-3343-5 Adverse drug reactions are one of the major constraints when using drugs. These adverse reactions can impact healthcare systems as strongly as many prevalent diseases. Identifying DNA variants associated with adverse drug reactions can help personalize medicine and sustain healthcare systems. This book delves into new advances in pharmacogenetics of cardiovascular, cancer, and nervous system drugs. It may be useful for clinicians and patients to understand the basics of pharmacogenetics.Medicinebicssc(es)citalopram5-fluorouracilacute coronary syndromeadverse drug reactionsadverse eventsalleleanti-epileptic drugs (AEDS)antiepilepticsantipsychotic agentsatorvastatincapecitabinecardiologycardiovascular diseaseclinical implementationclopidogrelcolorectal cancercutaneous adverse drug reactioncutaneous adverse drug reactions (CADRs)CYP2C9*3CYP450 enzymescytochrome P-450 enzyme systemdirect oral anticoagulantsdrug-drug-gene-interactiondrug-drug-interactiondrug-gene-interactionepistasisfluoropyrimidinegenetic polymorphismgenetic risk factorsgenotypeguidelinesHLAHLA BIndian/apersonalised medicinepharmacogeneticspharmacogenomicsphenytoin (PHT)platelet reactivitypolymorphismprecision medicinepsychotic disordersrandom forestSCARsingle-nucleotide variantsSLCO1B1South Indiastatinthe PharmLines initiativethymidylate synthasethymidylate synthase enhancer regiontoxicityupstream stimulatory factor 1MedicineLópez-Fernández Luis Aedt1319399López-Fernández Luis AothBOOK9910557610103321Pharmacogenetics to Avoid Adverse Drug Reactions3033877UNINA